• Company
• Entresto sales soar… rises 22% in 1 year
• by Kim, Jin-Gu Aug 6, 2024 09:15am

• Company
• Nabota records KRW 92B in North American sales in Q2
• by Son, Hyung-Min Aug 5, 2024 07:51am

• Company
• Pemazyre may be prescribed at general hospitals in Korea
• by Eo, Yun-Ho Aug 5, 2024 07:51am

• Company
• Obesity drugs, 'Wegovy vs Mounjaro' after expanded approval
• by Hwang, Byung-woo Aug 5, 2024 07:51am

• Company
• Pulmican·Pulmicort prescriptions surge in asthma Tx mkt
• by Chon, Seung-Hyun Aug 5, 2024 07:50am

• Company
• Bosulif, 2nd-generation leukemia drug available in Big 5
• by Eo, Yun-Ho Aug 5, 2024 07:50am

• Company
• Fresenius Kabi launches 2 Ntense amino acid solutions
• by Eo, Yun-Ho Aug 2, 2024 05:52am

• Company
• GC·Hanmi submit IND apl. for new 'Fabry disease' drug
• by Son, Hyung-Min Aug 2, 2024 05:52am

• Company
• Next Biomedical seeks IPO…knocks on global GI mkt
• by Hwang, Byung-woo Aug 2, 2024 05:52am

• Company
• Mounjaro bids into Korea's obesity treatment market
• by Hwang, Byung-woo Aug 2, 2024 05:51am